Prestige Consumer Healthcare Inc. (PBH)
Company Info
Highlights
$4.17B
$4.26
19.76
2.79
$841.01M
$458.75M
$268.16M
$62.35 - $90.04
$86.67
4.86%
4.04
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Prestige Consumer Healthcare Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Prestige Consumer Healthcare Inc. (PBH) returned 11.46% year-to-date (YTD) and 24.61% over the past 12 months. Over the past 10 years, PBH returned 7.86% annually, underperforming the S&P 500 benchmark at 10.43%.
PBH
11.46%
9.03%
8.68%
24.61%
16.74%
7.86%
^GSPC (Benchmark)
-3.70%
13.67%
-5.18%
9.18%
14.14%
10.43%
Monthly Returns
The table below presents the monthly returns of PBH, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | -1.69% | 10.39% | 1.44% | -5.51% | 7.15% | 11.46% | |||||||
| 2024 | 0.52% | 13.06% | 4.28% | -1.10% | -10.38% | 7.06% | 2.85% | 5.41% | -3.40% | 2.29% | 14.94% | -7.88% | 27.56% |
| 2023 | 5.05% | -8.38% | 3.95% | -1.76% | -6.99% | 3.84% | 9.73% | -10.55% | -1.95% | 3.79% | -3.39% | 6.75% | -2.20% |
| 2022 | -6.92% | 5.46% | -11.07% | 3.25% | 2.12% | 5.34% | 2.57% | -16.13% | -1.48% | 9.33% | 12.81% | 1.85% | 3.22% |
| 2021 | 14.71% | 4.28% | 5.68% | -1.18% | 14.49% | 4.47% | 0.86% | 9.21% | -2.23% | 6.91% | -6.73% | 8.40% | 73.93% |
| 2020 | 0.15% | -7.89% | -1.82% | 10.93% | 3.71% | -11.00% | -0.99% | -2.04% | -0.03% | -9.31% | 7.69% | -1.97% | -13.90% |
| 2019 | -9.59% | 4.80% | 2.22% | -1.64% | -1.33% | 9.13% | 9.22% | -7.86% | 8.81% | 2.22% | 6.51% | 7.23% | 31.15% |
| 2018 | -5.81% | -19.20% | -0.24% | -12.69% | 13.55% | 14.81% | -6.90% | 7.75% | -0.34% | -4.57% | 7.36% | -20.45% | -29.59% |
| 2017 | 1.27% | 7.32% | -1.87% | 3.33% | -12.25% | 4.82% | 1.55% | -5.44% | -1.22% | -6.37% | -3.62% | -1.75% | -14.76% |
| 2016 | -9.32% | 4.76% | 9.18% | 6.35% | -4.83% | 2.52% | -3.43% | -10.04% | 0.29% | -6.19% | 5.06% | 9.52% | 1.20% |
| 2015 | -1.32% | 12.49% | 11.29% | -8.49% | 11.90% | 5.28% | 2.98% | -2.31% | -2.92% | 8.53% | 3.84% | 1.16% | 48.27% |
| 2014 | -15.47% | -5.85% | -4.35% | 23.01% | 2.03% | -0.91% | -9.12% | 12.37% | -6.47% | 9.42% | -5.56% | 3.80% | -3.02% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
With an overall rank of 82, PBH is among the top 18% of stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Prestige Consumer Healthcare Inc. (PBH) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Prestige Consumer Healthcare Inc. provided a 0.00% dividend yield over the last twelve months, with an annual payout of $0.00 per share.
| Period | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Dividend | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.48 |
Dividend yield | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 1.54% |
Monthly Dividends
The table displays the monthly dividend distributions for Prestige Consumer Healthcare Inc.. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||
| 2024 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2023 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2022 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2021 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2020 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2019 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2018 | $0.48 | $0.00 | $0.00 | $0.00 | $0.48 |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the Prestige Consumer Healthcare Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Prestige Consumer Healthcare Inc. was 80.60%, occurring on Mar 11, 2009. Recovery took 935 trading sessions.
The current Prestige Consumer Healthcare Inc. drawdown is 2.22%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -80.6% | Jul 11, 2005 | 924 | Mar 11, 2009 | 935 | Nov 26, 2012 | 1859 |
| -53.16% | Mar 2, 2017 | 509 | Mar 11, 2019 | 608 | Aug 6, 2021 | 1117 |
| -26.77% | Dec 30, 2013 | 27 | Feb 6, 2014 | 190 | Nov 6, 2014 | 217 |
| -23.03% | Nov 12, 2021 | 219 | Sep 27, 2022 | 47 | Dec 2, 2022 | 266 |
| -21.39% | May 3, 2016 | 127 | Oct 31, 2016 | 80 | Feb 27, 2017 | 207 |
Volatility
Volatility Chart
The current Prestige Consumer Healthcare Inc. volatility is 10.41%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Prestige Consumer Healthcare Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Earnings Per Share
The chart presents the Earnings Per Share (EPS) performance of Prestige Consumer Healthcare Inc., comparing actual results with analytics estimates. In the past quarter, the company did not meet analyst expectations for EPS, resulting in a surprise of -100.0%.
Valuation
The Valuation section provides an overview of how Prestige Consumer Healthcare Inc. is priced in the market compared to other companies in the Medical Distribution industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for PBH, comparing it with other companies in the Medical Distribution industry. Currently, PBH has a P/E ratio of 19.8. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for PBH compared to other companies in the Medical Distribution industry. PBH currently has a PEG ratio of 2.8. This PEG ratio is higher than the industry average, which may suggest the stock is overvalued relative to its expected earnings growth.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for PBH relative to other companies in the Medical Distribution industry. Currently, PBH has a P/S ratio of 3.7. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for PBH in comparison with other companies in the Medical Distribution industry. Currently, PBH has a P/B value of 2.3. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |